(Sharecast News) - Shares in Denmark's Novo Nordisk surged on Tuesday after the US Food and Drug Administration approved the pill form of its Wegovy weight loss drug.
The Wegovy pill - the first oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy approved for weight management - is expected to be launched...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE